Clinical Trial Update: Pioglitazone in Alzheimer Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pioglitazone in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED